Zobrazeno 1 - 9
of 9
pro vyhledávání: '"LinYan Tian"'
Autor:
Wenqi Wu, Su Liu, Linyan Tian, Cheng Li, Yanan Jiang, Jinhuan Wang, Yangyang Lv, Jing Guo, Donghui Xing, Yixin Zhai, Huimeng Sun, Yuhang Li, Luying Zhang, Xiang He, Kaiping Luo, Hongjie Zhan, Zhigang Zhao
Publikováno v:
Frontiers in Genetics, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/5b72d4122ac34840ad4388358a49299f
Autor:
Wenqi Wu, Su Liu, Linyan Tian, Cheng Li, Yanan Jiang, Jinhuan Wang, Yangyang Lv, Jing Guo, Donghui Xing, Yixin Zhai, Huimeng Sun, Yuhang Li, Luying Zhang, Xiang He, Kaiping Luo, Hongjie Zhan, Zhigang Zhao
Publikováno v:
Frontiers in Genetics, Vol 13 (2023)
Background: Diffuse large B-cell lymphoma (DLBCL) is a genetically heterogeneous disease with a complicated prognosis. Even though various prognostic evaluations have been applied currently, they usually only use the clinical factors that overlook th
Externí odkaz:
https://doaj.org/article/14a7411f32b34b9d94307d0f47f8cf4e
Autor:
Linyan Tian, Cheng Li, Juan Sun, Yixin Zhai, Jinhuan Wang, Su Liu, Yanan Jiang, Wenqi Wu, Donghui Xing, Yangyang Lv, Jing Guo, Hong Xu, Huimeng Sun, Yuhang Li, Lanfang Li, Zhigang Zhao
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
BackgroundWe aimed to compare the efficacy of chimeric antigen receptor T (CAR-T) cell therapy with that of autologous stem cell transplantation (auto-HSCT) in relapsed/refractory diffuse large B cell lymphoma (R/R DLBCL).Research design and methodsW
Externí odkaz:
https://doaj.org/article/a229bc4fcdd846ff8708e80c9e3c7b29
Autor:
Yanan Jiang, Huimeng Sun, Hong Xu, Xin Hu, Wenqi Wu, Yangyang Lv, Jinhuan Wang, Su Liu, Yixin Zhai, Linyan Tian, Yafei Wang, Zhigang Zhao
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Diffuse large B cell lymphoma (DLBCL) exhibits a tightly complexity immune landscape. In this study, we intended to identify different immune phenotype and to examine the immune related mRNA signature for clinical characteristic, therapeutic responsi
Externí odkaz:
https://doaj.org/article/64205c273f7c49fa98b21ac55caafb05
Autor:
Hong Xu, Yuhang Li, Yanan Jiang, Jinhuan Wang, Huimeng Sun, Wenqi Wu, Yangyang LV, Su Liu, Yixin Zhai, LinYan Tian, Lanfang Li, Zhigang Zhao
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Background: Diffuse large B-cell lymphoma (DLBCL) is a genetically heterogeneous disease that can have profound differences in survival outcomes. A variety of powerful prognostic factors and models have been constructed; however, the development of m
Externí odkaz:
https://doaj.org/article/2f71b0bbb2184540983a1be669b4b9d5
Autor:
Wenqi Wu, Jinhuan Wang, Yanan Jiang, Xin Hu, Ye Tian, Long Chen, Huimeng Sun, Yuhang Li, Su Liu, Yangyang Lv, Jing Guo, Hong Xu, Donghui Xing, Yixin Zhai, Linyan Tian, Cheng Li, Xiang He, Kaiping Luo, Yuan Pan, Zhigang Zhao
Publikováno v:
Journal of Cancer. 14:403-416
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::547f12b997010851ba34f70017cbdc06
https://doi.org/10.7150/jca.80926
https://doi.org/10.7150/jca.80926
Autor:
Yixin Zhai, Jinhuan Wang, Yanan Jiang, Wenqi Wu, Yangyang Lv, Hong Xu, Linyan Tian, Huimeng Sun, Zhigang Zhao, Lanfang Li
Publikováno v:
Expert Review of Hematology. 15:265-272
Nodal peripheral T cell lymphoma (PTCL) confers a dismal prognosis when treated with conventional chemotherapy. Autologous stem cell transplantation (ASCT) seems a reasonable alternative in eligible patients. Nevertheless, a consensus on the role of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00b390ca494e9275b38e1e082def39ef
https://doi.org/10.1080/17474086.2022.2042247
https://doi.org/10.1080/17474086.2022.2042247
Autor:
Wenqi Wu, Yafei Wang, Yanan Jiang, Zhigang Zhao, Linyan Tian, Huimeng Sun, Jinhuan Wang, Hong Xu, Yangyang Lv, Su Liu, Yixin Zhai
Diffuse large B cell lymphoma (DLBCL) exhibits a tightly complexity immune landscape. In this study, we intended to identify different immune phenotype and to examine the immune related mRNA signature for clinical characteristic, therapeutic responsi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed0388d34c55fa797801128cd40a0e80
https://doi.org/10.21203/rs.3.rs-902940/v1
https://doi.org/10.21203/rs.3.rs-902940/v1
Autor:
Yafei Wang, Wenqi Wu, Huimeng Sun, Yangyang Lv, Linyan Tian, Yixin Zhai, Su Liu, Zhigang Zhao, Hong Xu, Donghui Xing, Yanan Jiang, Jinhuan Wang
Background: Allogeneic hematopoietic stem cell transplantation(allo-HSCT) consolidation therapy after chimeric antigen receptor(CAR) T cell therapy has emerged as an alternative in patients with B-ALL in the past decade. However, the efficiency remai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::621badba3a95adf2aa5943ac6b1c8ef3
https://doi.org/10.21203/rs.3.rs-677636/v1
https://doi.org/10.21203/rs.3.rs-677636/v1